Annual CAPEX:
$500.36M-$25.64M(-4.87%)Summary
- As of today, TEVA annual capital expenditures is $500.36 million, with the most recent change of -$25.64 million (-4.87%) on December 31, 2024.
- During the last 3 years, TEVA annual CAPEX has fallen by -$61.64 million (-10.97%).
- TEVA annual CAPEX is now -54.51% below its all-time high of $1.10 billion, reached on December 31, 2012.
Performance
TEVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$136.82M+$39.06M(+39.96%)Summary
- As of today, TEVA quarterly capital expenditures is $136.82 million, with the most recent change of +$39.06 million (+39.96%) on September 30, 2025.
- Over the past year, TEVA quarterly CAPEX has dropped by -$11.18 million (-7.55%).
- TEVA quarterly CAPEX is now -58.91% below its all-time high of $333.00 million, reached on December 31, 2016.
Performance
TEVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$490.58M-$11.18M(-2.23%)Summary
- As of today, TEVA TTM capital expenditures is $490.58 million, with the most recent change of -$11.18 million (-2.23%) on September 30, 2025.
- Over the past year, TEVA TTM CAPEX has increased by +$2.58 million (+0.53%).
- TEVA TTM CAPEX is now -55.81% below its all-time high of $1.11 billion, reached on March 31, 2013.
Performance
TEVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TEVA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -4.9% | -7.5% | +0.5% |
| 3Y3 Years | -11.0% | +12.2% | -12.2% |
| 5Y5 Years | -4.7% | -4.3% | -5.8% |
TEVA CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -11.0% | at low | -7.5% | +41.0% | -12.2% | +0.8% |
| 5Y | 5-Year | -13.4% | at low | -22.3% | +41.0% | -18.2% | +0.8% |
| All-Time | All-Time | -54.5% | +2143.8% | -58.9% | +485.1% | -55.8% | +1998.0% |
TEVA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $136.82M(+40.0%) | $490.58M(-2.2%) |
| Jun 2025 | - | $97.76M(-23.0%) | $501.76M(+0.2%) |
| Mar 2025 | - | $127.00M(-1.6%) | $501.00M(+0.6%) |
| Dec 2024 | $500.36M(-4.9%) | $129.00M(-12.8%) | $498.00M(+2.0%) |
| Sep 2024 | - | $148.00M(+52.6%) | $488.00M(+0.3%) |
| Jun 2024 | - | $97.00M(-21.8%) | $486.56M(-4.1%) |
| Mar 2024 | - | $124.00M(+4.2%) | $507.26M(-2.6%) |
| Dec 2023 | $526.00M(-3.6%) | $119.00M(-18.8%) | $520.95M(-3.8%) |
| Sep 2023 | - | $146.56M(+24.5%) | $541.81M(+4.7%) |
| Jun 2023 | - | $117.70M(-14.5%) | $517.25M(-1.8%) |
| Mar 2023 | - | $137.70M(-1.5%) | $526.55M(-3.5%) |
| Dec 2022 | $545.86M(-2.9%) | $139.86M(+14.6%) | $545.86M(-2.4%) |
| Sep 2022 | - | $122.00M(-3.9%) | $559.00M(-4.1%) |
| Jun 2022 | - | $127.00M(-19.1%) | $583.00M(+2.5%) |
| Mar 2022 | - | $157.00M(+2.6%) | $569.00M(+1.2%) |
| Dec 2021 | $562.00M(-2.8%) | $153.00M(+4.8%) | $562.00M(-3.9%) |
| Sep 2021 | - | $146.00M(+29.2%) | $585.00M(+0.5%) |
| Jun 2021 | - | $113.00M(-24.7%) | $582.00M(-3.0%) |
| Mar 2021 | - | $150.00M(-14.8%) | $600.00M(+3.8%) |
| Dec 2020 | $578.00M(+10.1%) | $176.00M(+23.1%) | $578.00M(+10.9%) |
| Sep 2020 | - | $143.00M(+9.2%) | $521.00M(-5.2%) |
| Jun 2020 | - | $131.00M(+2.3%) | $549.75M(+3.6%) |
| Mar 2020 | - | $128.00M(+7.6%) | $530.58M(+0.5%) |
| Dec 2019 | $525.00M(-19.1%) | $119.00M(-30.7%) | $528.08M(-14.8%) |
| Sep 2019 | - | $171.75M(+53.6%) | $619.97M(+5.6%) |
| Jun 2019 | - | $111.84M(-10.9%) | $587.22M(-3.8%) |
| Mar 2019 | - | $125.50M(-40.5%) | $610.34M(-5.8%) |
| Dec 2018 | $648.88M(-26.3%) | $210.88M(+51.7%) | $647.70M(-7.7%) |
| Sep 2018 | - | $139.00M(+3.0%) | $701.92M(-9.8%) |
| Jun 2018 | - | $134.96M(-17.1%) | $778.58M(-7.2%) |
| Mar 2018 | - | $162.85M(-38.6%) | $838.90M(-4.8%) |
| Dec 2017 | $880.79M(-2.6%) | $265.11M(+22.9%) | $880.79M(-7.2%) |
| Sep 2017 | - | $215.66M(+10.4%) | $948.68M(-0.6%) |
| Jun 2017 | - | $195.28M(-4.6%) | $954.01M(+2.2%) |
| Mar 2017 | - | $204.73M(-38.5%) | $933.73M(+3.6%) |
| Dec 2016 | $904.04M(+17.1%) | $333.00M(+50.7%) | $901.00M(+10.4%) |
| Sep 2016 | - | $221.00M(+26.3%) | $816.00M(+6.7%) |
| Jun 2016 | - | $175.00M(+1.7%) | $765.00M(+0.8%) |
| Mar 2016 | - | $172.00M(-30.6%) | $759.00M(-1.7%) |
| Dec 2015 | $772.00M(-16.9%) | $248.00M(+45.9%) | $772.00M(-6.3%) |
| Sep 2015 | - | $170.00M(+0.6%) | $824.00M(-4.8%) |
| Jun 2015 | - | $169.00M(-8.6%) | $866.00M(-2.6%) |
| Mar 2015 | - | $185.00M(-38.3%) | $889.00M(-4.3%) |
| Dec 2014 | $929.00M(-9.9%) | $300.00M(+41.5%) | $929.00M(-0.6%) |
| Sep 2014 | - | $212.00M(+10.4%) | $934.69M(-0.9%) |
| Jun 2014 | - | $192.00M(-14.7%) | $943.13M(-4.1%) |
| Mar 2014 | - | $225.00M(-26.4%) | $983.51M(-4.6%) |
| Dec 2013 | $1.03B(-6.3%) | $305.69M(+38.7%) | $1.03B(-2.2%) |
| Sep 2013 | - | $220.44M(-5.1%) | $1.05B(-3.1%) |
| Jun 2013 | - | $232.38M(-14.6%) | $1.09B(-2.1%) |
| Mar 2013 | - | $272.12M(-17.2%) | $1.11B(+0.9%) |
| Dec 2012 | $1.10B | $328.70M(+29.6%) | $1.10B(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $253.68M(-0.7%) | $1.08B(-1.3%) |
| Jun 2012 | - | $255.54M(-2.5%) | $1.10B(+2.6%) |
| Mar 2012 | - | $262.02M(-16.1%) | $1.07B(+2.2%) |
| Dec 2011 | $1.05B(+47.7%) | $312.38M(+16.7%) | $1.05B(+8.1%) |
| Sep 2011 | - | $267.70M(+17.5%) | $968.61M(+10.9%) |
| Jun 2011 | - | $227.78M(-4.8%) | $873.49M(+11.5%) |
| Mar 2011 | - | $239.18M(+2.2%) | $783.11M(+10.5%) |
| Dec 2010 | $708.81M(-1.2%) | $233.96M(+35.6%) | $708.81M(+2.0%) |
| Sep 2010 | - | $172.58M(+25.6%) | $695.14M(-1.8%) |
| Jun 2010 | - | $137.40M(-16.7%) | $707.71M(-1.5%) |
| Mar 2010 | - | $164.87M(-25.2%) | $718.60M(+0.3%) |
| Dec 2009 | $717.60M(+5.0%) | $220.29M(+19.0%) | $716.75M(+44.4%) |
| Sep 2009 | - | $185.15M(+24.9%) | $496.46M(+59.5%) |
| Jun 2009 | - | $148.29M(-9.0%) | $311.31M(-8.1%) |
| Mar 2009 | - | $163.02M(-7.3%) | $338.91M(-42.1%) |
| Dec 2008 | $683.48M(+26.9%) | - | - |
| Jun 2008 | - | $175.89M(+24.7%) | $585.36M(+11.6%) |
| Mar 2008 | - | $141.10M(-2.2%) | $524.59M(-2.7%) |
| Dec 2007 | $538.71M(+38.8%) | $144.25M(+16.2%) | $539.24M(+3.1%) |
| Sep 2007 | - | $124.12M(+7.8%) | $523.23M(+5.5%) |
| Jun 2007 | - | $115.12M(-26.1%) | $495.85M(+5.2%) |
| Mar 2007 | - | $155.75M(+21.5%) | $471.29M(+21.4%) |
| Dec 2006 | $388.06M(+16.1%) | $128.24M(+32.6%) | $388.06M(+13.0%) |
| Sep 2006 | - | $96.74M(+6.8%) | $343.37M(+4.4%) |
| Jun 2006 | - | $90.56M(+24.9%) | $328.83M(+8.0%) |
| Mar 2006 | - | $72.52M(-13.2%) | $304.39M(-2.0%) |
| Dec 2005 | $334.31M(-1.3%) | $83.55M(+1.6%) | $310.76M(-4.9%) |
| Sep 2005 | - | $82.20M(+24.3%) | $326.62M(+2.0%) |
| Jun 2005 | - | $66.12M(-16.2%) | $320.29M(-1.8%) |
| Mar 2005 | - | $78.89M(-20.6%) | $326.08M(+4.8%) |
| Dec 2004 | $338.66M(+50.6%) | $99.42M(+31.0%) | $311.15M(+12.9%) |
| Sep 2004 | - | $75.87M(+5.5%) | $275.62M(+38.0%) |
| Jun 2004 | - | $71.91M(+12.4%) | $199.75M(+56.2%) |
| Mar 2004 | - | $63.96M(+0.1%) | $127.85M(+100.1%) |
| Dec 2003 | $224.84M(+20.9%) | $63.89M(+67.4%) | $63.89M(-54.3%) |
| Dec 2002 | $185.95M(+38.7%) | - | - |
| Jun 2002 | - | $38.17M(+39.3%) | $139.92M(+1.3%) |
| Mar 2002 | - | $27.40M(-36.4%) | $138.08M(+3.0%) |
| Dec 2001 | $134.07M(+19.8%) | $43.07M(+37.7%) | $134.07M(+47.3%) |
| Sep 2001 | - | $31.28M(-13.9%) | $91.00M(+52.4%) |
| Jun 2001 | - | $36.34M(+55.4%) | $59.72M(+155.4%) |
| Mar 2001 | - | $23.38M | $23.38M |
| Dec 2000 | $111.94M(-64.3%) | - | - |
| Dec 1999 | $313.79M(+38.4%) | - | - |
| Dec 1998 | $226.73M(+231.3%) | - | - |
| Dec 1997 | $68.44M(-19.7%) | - | - |
| Dec 1996 | $85.25M(+5.8%) | - | - |
| Dec 1995 | $80.55M(+13.3%) | - | - |
| Dec 1994 | $71.10M(+76.2%) | - | - |
| Dec 1993 | $40.35M(+24.7%) | - | - |
| Dec 1992 | $32.35M(+45.1%) | - | - |
| Dec 1991 | $22.30M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual capital expenditures?
- What is the all-time high annual CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
- What is the all-time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
What is Teva Pharmaceutical Industries Limited annual capital expenditures?
The current annual CAPEX of TEVA is $500.36M
What is the all-time high annual CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual capital expenditures is $1.10B
What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
Over the past year, TEVA annual capital expenditures has changed by -$25.64M (-4.87%)
What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
The current quarterly CAPEX of TEVA is $136.82M
What is the all-time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly capital expenditures is $333.00M
What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
Over the past year, TEVA quarterly capital expenditures has changed by -$11.18M (-7.55%)
What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
The current TTM CAPEX of TEVA is $490.58M
What is the all-time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM capital expenditures is $1.11B
What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
Over the past year, TEVA TTM capital expenditures has changed by +$2.58M (+0.53%)